Iron measured by MRI in vivo would contribute to searching for iron-related biomarkers in neurodegenerative diseases, like Parkinson's disease.
Here, we would like to briefly introduce the technological development of MRI in assessing brain iron, discuss the nigral iron as a potential marker for PD in both clinical and prodromal stages, further put insight into other influences of regional iron on PD symptoms.
This abstract and the presentation materials are available to members only; a login is required.